Wakefield Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,247
Closed -$3.76M 160
2024
Q3
$3.76M Buy
4,247
+33
+0.8% +$29.7K 1.22% 24
2024
Q2
$3.82M Buy
+4,214
New +$3.37M 1.34% 17
2019
Q1
Sell
-230
Closed -$27K 229
2018
Q4
$27K Buy
+230
New +$25.7K 0.01% 181

Other funds holding LLY

Wakefield Asset Management's LLY Position: Q4 2024 in Review

Wakefield Asset Management sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 4,247 shares — an estimated $3.76M sold.

Wakefield Asset Management first reported a position in LLY in Q4 2018 and held it in 3 quarters. The position peaked at $3.82M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Wakefield Asset Management reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Wakefield Asset Management sold 4,247 Eli Lilly shares in Q4 2024, an estimated $3.76M.
  • Wakefield Asset Management first reported a position in Eli Lilly in Q4 2018 and held it in 3 quarters.
  • Wakefield Asset Management's Eli Lilly position peaked at $3.82M in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Wakefield Asset Management's 13F filing for Q4 2024, filed 5 Feb 2025.